NON-FINAL ACTION - MAILED
final action
on 02 Oct 2024
Last Applicant/ Owned by
Scheelevagen 2 SE-223 81 Lund
XP
Serial Number
79399250 filed on 14th Mar 2024
Registration Number
N/A
Correspondent Address
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
RUBY
Bio-technology and scientific research services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; research, production and development services relating to antibodies, proteins and enzymes; biological and bio-technology analysis services and laboratory se Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Bio-technology and scientific research services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; research, production and development services relating to antibodies, proteins and enzymes; biological and bio-technology analysis services and laboratory services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Proteins; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical use; enzymes for medical purposes; diagnostic reagents; antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Proteins for use in science, industry or manufacture; enzymes; polymers; chemical and biochemical preparations and substances used in industry, agriculture or foodstuffs; chemical diagnostic reagents for industrial use; diagnostic reagents for scientific use; chemicals for analytical, diagnostic and immunological purposes and laboratory use; chemicals for use in the manufacture of pharmaceuticals; libraries and collections of the aforementioned chemicals; antibodies for scientific purposes, other than for medical or veterinary use; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79399250
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Oct 2024 | REFUSAL PROCESSED BY IB |
| 02th Oct 2024 | REFUSAL PROCESSED BY MPU |
| 02th Oct 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 27th Sep 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 26th Sep 2024 | NON-FINAL ACTION WRITTEN |
| 24th Sep 2024 | ASSIGNED TO EXAMINER |
| 11th Jul 2024 | APPLICATION FILING RECEIPT MAILED |
| 11th Jul 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 04th Jul 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |